The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/II trial of pembrolizumab(P) and vorinostat(V) in recurrent metastatic head and neck squamous cell carcinomas (HN) and salivary gland cancer (SGC).
 
Cristina P. Rodriguez
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Ignyta (Inst); Merck (Inst)
 
Vicky Wu
No Relationships to Disclose
 
Jenna M. Voutsinas
No Relationships to Disclose
 
Jonathan P Fromm
Research Funding - Merck
 
Venu Gopal Pillarisetty
Research Funding - Merck Sharp & Dohme (Inst)
 
Sylvia Lee
No Relationships to Disclose
 
Rafael Santana-Davila
Consulting or Advisory Role - ARIAD; Boehringer Ingelheim
Research Funding - Abbvie (Inst); Bayer (Inst); BeyondSpring Pharmaceuticals (Inst); Genentech (Inst); Lilly (Inst)
 
Bernardo H. L. Goulart
No Relationships to Disclose
 
Christina S. Baik
Consulting or Advisory Role - Novartis
Research Funding - AstraZeneca (Inst); Celgene (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Loxo (Inst); MedImmune (Inst); Merck Sharp & Dohme (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst)
 
Laura Quan Man Chow
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Genentech; genzyme; Merck; Novartis; pfizer; Seagen
Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Genzyme (Inst); Incyte (Inst); Lilly/ImClone (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); VentiRx (Inst)
 
Keith D. Eaton
Research Funding - Eisai (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); Resolution Bioscience (Inst)
 
Renato G. Martins
Research Funding - Eisai (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst)